Sarah Enslin, PA-C

Adherence starts with finding a treatment patients can realistically sustain. The expert faculty discuss how shared decision-making and patient education can help translate an EoE treatment plan into long-term action.

Effective EoE management requires more than controlling disease activity. The panel explores how evolving clinical needs and quality-of-life considerations can guide treatment decisions over time.

EoE monitoring does not end when remission is achieved. The panel explores how individualized surveillance and ongoing patient engagement can help clinicians recognize changes in disease control over time.

Feeling better does not always mean EoE is fully controlled. The panel explores how patient goals, symptoms, endoscopic findings, and histology come together to provide a more complete picture of treatment success.

Biologic evidence in EoE is expanding beyond traditional measures of response. The panel explores how data on esophageal distensibility and pediatric outcomes may refine patient selection and inform clinical decision-making.

Long-term EoE management requires evidence that extends beyond initial treatment response. The panel examines 4-year BOS data and what they reveal about durability of response, tolerability, and sustained disease control.

Effective EoE care requires a treatment plan that works for both the disease and the patient. The expert faculty explore how individualized treatment selection and appropriately timed reassessment can support sustained disease control.

Achieving remission is only one phase of EoE care. The panel explores how induction and maintenance therapies can work together to control inflammation and sustain disease control over time.

Diagnostic delays in EoE can have consequences beyond persistent symptoms. The panel explores how earlier recognition and collaborative care may help address progressive esophageal remodeling and reduce long-term disease burden.

Early EoE diagnosis is about more than relieving symptoms today. The panel explores how timely recognition and treatment of inflammation may help limit progressive structural changes and protect long-term esophageal health.

Accurate EoE diagnosis requires more than recognizing symptoms. The expert faculty highlight how clinical suspicion, appropriate biopsy sampling, histology, and endoscopic findings come together to establish a confident diagnosis.

EoE does not always present as straightforward dysphagia. The panel explores how adaptive eating behaviors, age-specific presentations, atopic comorbidities, and food impaction can provide critical clues for earlier recognition and diagnosis.

In the final episode, each panelist synthesizes their top recommendations for advancing EPI care.

This episode spotlights a recent publication by Ashkar and colleagues—co-authored by Jennifer Geremia—surveying prescribing practices for EPI across a broad cross-section of healthcare professionals.

Clinicians reveal where pancreatic care falls apart—diagnosis delays, post-discharge gaps, lost oncology follow-up—and how to fix handoffs fast.

Why EPI outcomes improve when GI, primary care, nutrition and pain teams coordinate—streamlining labs, vitamins and follow-ups for patients.

Learn how clinicians tailor pancreatic enzyme therapy: insurance, dosing, PPIs, and fixes for nonresponse—plus limits of OTC enzymes.

Learn what happens after suspected EPI: patient education, enzyme therapy tips, nutrition and vitamin checks, plus smoking and alcohol support.

Clinicians weigh PEI questionnaires, symptom scores, and AGA updates to track exocrine pancreatic insufficiency and tailor patient-centered care.

Learn a stepwise approach to evaluating EPI-like diarrhea—history, alarm features, fecal elastase and imaging—to rule out IBS, celiac, IBD.

Learn how primary care, APPs, and specialists collaborate to spot symptoms, refer fast, and follow guidelines for accurate GI diagnosis.

Clinicians across specialties spot red flags, refer early to GI, and follow guidelines to improve diagnosis and management.

Why EPI stays missed: barriers to enzyme therapy, targeted fecal elastase testing, and preventing malnutrition, bone loss, and QoL decline.

Sarah Enslin, PA-C, and Jennifer Geremia, PA-C, discuss the diagnosis and management of EPI, reflecting on ongoing challenges in the field.

Panelists discuss the wide range of pancreatic and non-pancreatic conditions that increase suspicion for exocrine pancreatic insufficiency to improve identification of high-risk patients.

Panelists discuss recognizing the varied and often atypical symptoms of exocrine pancreatic insufficiency to improve early diagnosis and clinical awareness.